Pillstats
Rx only · Tablet · Oral

Emtricitabine And Tenofovir Disoproxil Fumarate

Emtricitabine + Tenofovir Disoproxil Fumarate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)300195
US makers3 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.151$0.301$0.452$0.603Dec 2025Mar 2026May 2026
$0.451
Latest avg · May 20, 2026
-14%
Since Dec 17, 2025
3
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

Only one quarter on record so far — the trend line fills in as more quarters load.

11
Rx · 2026 Q1
510
Units dispensed
1
Quarters · since 2026 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Golden State Medical Supply, Inc.unknown1SUPPLYING
Strides Pharma Inc.unknown1SUPPLYING
Strides Pharma Science Limitedunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.